Processing of DR1-restricted determinants from the fusion protein of measles virus following two distinct pathways

Molecular Immunology

Volumn 33, Issue 4-5, 1996, Pages 387-397

  Demotz, Stéphane ^a   Péléraux, Annick ^b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b INSERM   (France)

Author keywords

Antigen processing; DR; fusion protein; measles virus

Indexed keywords

BREFELDIN A; CHLOROQUINE; HYBRID PROTEIN; LEUPEPTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; POLYPEPTIDE; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CALCIUM TRANSPORT; CELL CLONE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MEASLES VIRUS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

MEASLES VIRUS;

EID: 18744430792     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/0161-5890(95)00148-4     Document Type: Article

References (46)

1. Adorini L., Appella E., Doria G., Cardinaux F. and Nagy Z. A. (1989) Competition for antigen presentation in living cells involves exchange of peptides bound by class II MHC molecules. Nature 342, 800-803.
2. Adorini L., Ullrich S. J., Appella E. and Fuchs S. (1990) Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells. Nature 346, 63-66.
3. Amigorena S., Drake J. R., Webster P. and Mellman I. (1994) Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature 369, 113-120.
4. Amigorena S., Webster P., Drake J., Newcomb J., Cresswell P. and Mellman I. (1995) Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles. J. exp. Med. 181, 1729-1741.
5. Blum J. S. and Cresswell P. (1988) Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc. natn. Acad. Sci. U.S.A. 85, 3975-3979.
6. k class II molecules in human APC containing deleted or mutated HLA DM genes. J. Immun. 153, 5382-5392.
7. Castellino F. and Germain R. N. (1995) Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded class II in multiple compartments. Immunity 2, 73-88.
8. Ceman S., Rudersdorf R. A., Petersen J. M. and DeMars R. (1995) DMA and DMB are the only genes in the class II region of the human MHC needed for class II-associated antigen processing. J. Immun. 154, 2545-2556.
9. Coeshott C. M., Chesnut R. W., Kubo R. T., Grammer S. F., Jenis D. M. and Grey H. M. (1986) Ia-specific mixed leucocyte reactive T cell hybridomas: Analysis of their specificity by using purified class II MHC molecules in a synthetic membrane system. J. Immun. 136, 2832-2838.
10. DeKroon A. and McConnell H. M. (1994) Kinetics and specificity of peptide-MHC class II complex displacement reactions. J. Immun. 152, 609-619.
11. Demotz S., Lanzavecchia A., Eisel U., Niemann H., Widmann C. and Corradin G. (1989) Delineation of several DR-restricted tetanus toxin T cell epitopes. J. Immun. 142, 394-402.
12. Demotz S. and Danieli C. (1993) Release of DR molecules from complexes with invariant chain through the formation of a C-terminal 25 kDa invariant chain fragment. Molec. Immun. 30, 1623-1632.
13. Demotz S., Barbey C., Corradin G., Amoroso A. and Lanzavecchia A. (1993) The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86. Eur. J. Immun. 23, 425-432.
14. Denzin L. K., Robbins N. F., Carboy-Newcomb C. and Cresswell P. (1994) Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells. Immunity 1, 595-606.
15. Denzin L. K. and Cresswell P. (1995) HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell 82, 155-165.
16. Diment S. and Shinde S. (1995) Selective processing of exogenous antigens by antigen-presenting cells with deleted MHC genes. J. Immun. 154, 530-535.
17. Fling S. P. and Arp B., Pious D. (1994) HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature 368, 554-558.
18. Germain R. N. and Margulies D. H. (1993) The biochemistry and cell biology of antigen processing and presentation. A. Rev. Immun. 11, 403-450.
19. Gorga J. C., Horejsi V., Johnson D. R., Raghupathy R. and Strominger J. L. (1987) Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line. J. biol. Chem. 262, 16087-16094.
20. Guy K., van Heyningen V., Cohen B. B., Deane D. L. and Steel C. M. (1982) Differential expression and serologically distinct subpopulations of human Ia antigens detected with monoclonal antibodies to Ia α and β chains. Eur. J. Immun. 12, 942-948.
21. Harding C. V., Roof R. W. and Unanue E. R. (1989) Turnover of Ia-peptide complexes is facilitated in viable antigen-presenting cells: Biosynthetic turnover of Ia vs. peptide exchange. Proc. natn. Acad. Sci. U.S.A. 86, 4230-4234.
22. Karlsson L., Péléraux A., Lindstedt R., Liljedahl M. and Peterson P. A. (1994) Reconstitution of an operational MHC class II compartment in non-antigen-presenting cells. Science 266, 1569-1573.
23. Lanzavecchia A., Reid P. A. and Watts C. (1992) Irreversible association of peptides with class II MHC molecules in living cells. Nature 357, 249-252.
24. Lippincott-Schwartz J., Yuan L., Tipper C., Amherdt M., Orci L. and Klausner R. D. (1991) Brefeldin A's effects on endosomes, lysosomes, and the TGN suggest a general mechanism for regulating organelle structure and membrane traffic. Cell 67, 601-616.
25. Lotteau V., Teyton L., Péléraux A., Nilsson T., Karlsson L., Schmid S. L., Quaranta V. and Peterson P. A. (1990) Intracellular transport of class II MHC molecules directed by invariant chain. Nature 348, 600-605.
26. Morris P., Shaman J., Attaya M., Amaya M., Goodman S., Bergman C., Monaco J. J. and Mellins E. (1994) An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 368, 551-554.
27. Nelson C. A., Petzold S. J. and Unanue E. R. (1994) Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell. Nature 371, 250-252.
28. Nilsson T., Jackson M. and Peterson P. A. (1989) Short cytoplasmic sequences serve as retention signals for transmembrane proteins in the endoplasmic reticulum. Cell 58, 707-718.
29. Pedrazzini T., Sette A., Albertson M. and Grey H. M. (1991) Free ligand-induced dissociation of MHC-antigen complexes. J. Immun. 146, 3496-3501.
30. Pinet V., Malnati M. S. and Long E. O. (1994) Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen. J. Immun. 152, 4852-4860.
31. Pinet V., Vergelli M., Martin R., Bakke O. and Long E. O. (1995) Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature 375, 603-606.
32. Qiu Y., Xu X., Wandinger-Ness A., Dalke D. P. and Pierce S. K. (1994) Separation of subcellular compartments containing distinct functional forms of MHC class II. J. cell. Biol. 125, 595-605.
33. Reay P. A., Wettstein D. A. and Davis M. M. (1992) pH dependence and exchange of high and low responder peptides binding to a class II MHC molecule. Eur. molec. Biol. Org. J. 11, 2829-2839.
34. Riberdy J. M. and Cresswell P. (1992) The antigen-processing mutant T2 suggests a role for MHC-linked genes in class II antigen presentation. J. Immun. 148, 2586-2590.
35. Sanderson F., Kleijmeer M. J., Kelly A., Verwoerd D., Tulp A., Neefjes J. J., Geuze H. J. and Trowsdale J. (1994) Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science 266, 1566-1569.
36. Sekaly R. P., Jacobson S., Richert J. R., Tonnelle C., McFarland H. F. and Long E. O. (1988) Antigen presentation to HLA class II-restricted measles virus-specific T-cell clones can occur in the absence of the invariant chain. Proc. natn. Acad. Sci. U.S.A. 85, 1209-1212.
37. Sherman M. A., Weber D. A. and Jensen P. E. (1995) DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 3, 197-205.
38. Sloan V. S., Cameron P., Porter G., Gammon M., Amaya M., Mellins E. and Zaller D. M. (1995) Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375, 802-806.
39. Stebbins C. C., Loss Jr. G. E., Elias C. G., Chervonsky A. and Sant A. J. (1995) The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent. J. exp. Med. 181, 223-234.
40. Tulp A., Verwoerd D., Dobberstein B., Ploegh H. L. and Pieters J. (1994) Isolation and characterization of the intracellular MHC class II compartment. Nature 369, 120-126.
41. + cytotoxic T cell clones. J. Immun. 142, 2847-2854.
42. + class I MHC-restricted CTL. J. Immun. 144, 2394-2399.
43. van Binnendijk R. S., van Baalen C. A., Poelen M. C. M., de Vries P., Boes J., Cerundolo V., Osterhaus A.D.M.E. and Uyt deHaag F.G.C.M. (1992) Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition. J. exp. Med. 176, 119-128.
44. West M. A., Lucocq J. M. and Watts C. (1994) Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells. Nature 369, 147-150.
45. Wild T. F., Bernard A., Spehner D. and Drillien R. (1992) Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice. J. gen. Virol. 73, 359-367.
46. Wood S. A., Park J. E. and Brown W. J. (1991) Brefeldin A causes a microtubule-mediated fusion of the trans-Golgi network and early endosomes. Cell 67, 591-600.